Rahul Agarwal

Spiro[pyrrolidine-3, 3´-oxindole] as potent anti-breast cancer compounds: Their design, synthesis, biological evaluation and cellular target identification

Santanu Hati, Sayantan Tripathy, Pratip Kumar Dutta et al. · Scientific Reports · 2016 · 84 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity

Papiya Majumdar, Chandramohan Bathula, Suparna Mercy Basu et al. · European Journal of Medicinal Chemistry · 2015 · 80 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets

Rahul Agarwal, Jitendra Narayan, Amitava Bhattacharyya et al. · Cancer Genetics · 2017 · 77 citations · Full text

Medicine, Molecular Biology, Oncology +17

NGS-based transcriptome profiling reveals biomarkers for companion diagnostics of the TGF-β receptor blocker galunisertib in HCC

Yuan Cao, Rahul Agarwal, Francesco Dituri et al. · Cell Death and Disease · 2017 · 52 citations · Full text

Medicine, Cancer Biology, Oncology +17

Design, synthesis and biological evaluation of small molecules as potent glucosidase inhibitors

Santanu Hati, Sanjay M. Madurkar, Chandramohan Bathula et al. · European Journal of Medicinal Chemistry · 2015 · 29 citations

Pharmacy, Biochemistry, Medicinal Chemistry +16